share_log

HC Wainwright & Co. Reiterates Buy on Biotricity, Raises Price Target to $4

Benzinga ·  Jul 5, 2023 07:26

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and raises the price target from $2 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment